United States · Wires & real time · PR Newswire

Hengrui Pharma presenta en el Congreso ESMO 2026 64 resultados de investigación en su cartera de oncología

Published by PR Newswire · United States 1 h ago

-Hengrui Pharma presenta en el Congreso ESMO 2026 64 resultados de investigación en su innovadora cartera de oncología Se han aceptado 64 hallazgos, incluidas tres presentaciones…

Read the full article on PR Newswire Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.prnewswire.com)

Also worth reading

Business Wire

Accenture, Dragos and SANS Institute Launch Foundation to Strengthen Cyber Defenses for Under-Resourced U.S. Utilities

Associated Press (Business)

Houthi strikes on Saudi Arabia show the Yemeni rebels’ growing strength

Dow Jones Newswires

Episode 49: Trump’s Tariffs Give Forced-Labor Activists an Opening

MT Newswires